Personalized Medicine: Will Dentistry Ride the Wave or Watch From the Beach?

Journal of Dental Research

Volumn 91, Issue , 2012, Pages S8-S11

  Kornman, K S ^a   Duff, G W ^b  

^a Interleukin Genetics   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

biological markers; disease susceptibility; genetic testing; periodontitis; personalized medicine; pharmacogenetics

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHRONIC DISEASE; CLASSIFICATION; DECISION MAKING; DENTAL CARIES; DENTISTRY; FORECASTING; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUTH DISEASE; NEOPLASM; PERIODONTITIS; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; RISK ASSESSMENT; TEMPOROMANDIBULAR JOINT DISORDER;

BIOLOGICAL MARKERS; CHRONIC DISEASE; DECISION MAKING; DENTAL CARIES; DENTISTRY; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIVIDUALIZED MEDICINE; MOUTH DISEASES; NEOPLASMS; PERIODONTITIS; PHARMACOGENETICS; PHENOTYPE; RISK ASSESSMENT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 84864141711     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034512449171     Document Type: Article

References (24)

1. Al-Tarawneh SK Border MB Dibble CF Bencharit S (2011). Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. OMICS 15: 353-361.
2. Ayhan H Suskan E Yildirim S (1996). The effect of nursing or rampant caries on height, body weight and head circumference. J Clin Pediatr Dent 20: 209-212.
3. Brodeur J-M Galarneau C (2006). The high incidence of Early Childhood Caries in kindergarten-age children. Journal de l'Ordre des dentistes du Quebec April(4 Suppl):3S-5S.
4. Cox A Camp NJ Cannings C di Giovine FS Dale M Worthington J. (1999). Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet 8: 1707-1713.
5. Dworkin SF LeResche L (1992). Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6: 301-355.
6. Emery P Dorner T (2011). Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann Rheum Dis 70: 2063-2070.
7. FDA (2012). Table of Pharmacogenomic Biomarkers in Drug Labels. US Food and Drug Administration. URL accessed on 5/1/2012 at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.
8. Garrod AE (1902). The incidence of alkaptonuria: a study in chemical individuality. Lancet 160: 1616-1620.
9. Herr MM Fries KM Upton LG Edsberg LE (2011). Potential biomarkers of temporomandibular joint disorders. J Oral Maxillofac Surg 69: 41-47.
10. Hildebrandt G Larson TD (2009). Management of rampant caries. Northwest Dent 88: 35-37, 39-41, 43-45 passim.
11. Hirschfeld L Wasserman B (1978). A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol 49: 225-237.
12. Hood L Heath JR Phelps ME Lin B (2004). Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643.
13. Lindhe J Nyman S (1984). Long-term maintenance of patients treated for advanced periodontal disease. J Clin Periodontol 11: 504-514.
14. Löe H Anerud A Boysen H Morrison E (1986). Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 13: 431-445.
15. Matsumoto K Honda K Ohshima M Yamaguchi Y Nakajima I Micke P. (2006). Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: a preliminary study. Dentomaxillofac Radiol 35: 432-441.
16. McLean JS Fansler SJ Majors PD McAteer K Allen LZ Shirtliff ME. (2012). Identifying low pH active and lactate-utilizing taxa within oral microbiome communities from healthy children using stable isotope probing techniques. PLoS One 7: e32219.
17. Mendelsohn J Ringborg U Schilsky RL (2012). Personalized cancer medicine - A strategy to counteract an increasing cancer challenge. Mol Oncol [Epub ahead of print 3/13/2012] (in press).
18. Meulenbelt I Kraus VB Sandell LJ Loughlin J (2011). Summary of the OA biomarkers workshop 2010 - genetics and genomics: new targets in OA. Osteoarthritis Cartilage 19: 1091-1094.
19. Okeson JP (1997). Current terminology and diagnostic classification schemes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 61-64.
20. Page RC (1995). Critical issues in periodontal research. J Dent Res 74: 1118-1128.
21. Rudney JD Staikov RK Johnson JD (2009). Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 54: 91-100.
22. Saijo N (2012). Present status and problems on molecular targeted therapy of cancer. Cancer Res Treat 44: 1-10.
23. Vogel F (1959). Moderne problem der humangenetik. Ergeb Inn Med U Kinderheilk 12: 52-125 (in German).
24. Wadelius M Pirmohamed M (2007). Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J 7: 99-111.